Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Black caraway seed (Nigella sativa) derives its primary therapeutic effects from thymoquinone (30–48% of essential oil), which inhibits NF-κB signaling to suppress pro-inflammatory cytokines TNF-α, IL-6, and IL-1β while exhibiting potent antioxidant activity (IC50 ~0.017 mg/mL, DPPH assay) (PMID 34073784; PMID 39807848). A comprehensive 2024 review in the International Journal of Molecular Sciences confirmed broad-spectrum pharmacological properties including immunomodulatory, antidiabetic, hepatoprotective, antimicrobial, and anticancer effects supported by in vitro, animal, and human clinical trial evidence (PMID 39769174).
Reported Benefits (Provisional)
Origin & History
Black Caraway Seed (Nigella sativa), often known as Black Cumin, is an annual flowering plant native to the Mediterranean region, Western Asia, and parts of Europe. Its potent seeds are revered for a rich profile of bioactive compounds. In functional nutrition, it is highly valued for its immune-modulating, anti-inflammatory, and metabolic-regulating properties.
Research Narrative (Provisional)
A 2021 comprehensive review in Nutrients (Hannan et al., PMID 34073784) analyzed over 900 studies confirming thymoquinone's anti-inflammatory, antioxidant, anticancer, and neuroprotective activities in both preclinical models and human clinical trials. Alberts et al. (2024) published a systematic review in the International Journal of Molecular Sciences (PMID 39769174) documenting Nigella sativa's clinically validated efficacy in managing type 2 diabetes, dyslipidemia, hypertension, and respiratory conditions. Chatterjee et al. (2025) in the Journal of Medicinal Food (PMID 39807848) provided updated evidence for thymoquinone's antimicrobial effects against drug-resistant pathogens and its synergistic antioxidant capacity when combined with other seed-derived bioactives. Earlier foundational work by Ahmad et al. (2013) in Asian Pacific Journal of Tropical Biomedicine (PMID 23646296) and Kooti et al. (2016) in Chinese Journal of Natural Medicines (PMID 28236403) catalogued over 150 pharmacological properties spanning hepatoprotective, nephroprotective, gastroprotective, and immunomodulatory domains.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Essential fatty acids, dietary fiber - Vitamins: Vitamin E - Phytochemicals: Thymoquinone, alkaloids
Reported Mechanism (Provisional)
Thymoquinone, the principal bioactive constituent (30–48% of Nigella sativa essential oil), exerts anti-inflammatory effects primarily by inhibiting the NF-κB signaling cascade, thereby downregulating transcription of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, as well as suppressing cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and matrix metalloproteinases (MMPs) (PMID 34073784; PMID 39769174). Its antioxidant mechanism involves direct scavenging of superoxide anions and hydroxyl radicals, upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), and preservation of intracellular glutathione (GSH) levels through Nrf2 pathway activation (PMID 39807848). Thymoquinone also modulates the PI3K/Akt/mTOR and MAPK/ERK pathways, contributing to its antiproliferative and pro-apoptotic effects in cancer cell lines, while simultaneously activating AMPK signaling to improve insulin sensitivity and hepatic glucose metabolism (PMID 34073784; PMID 24111621). Additional bioactive components—thymohydroquinone, thymol, carvacrol, and α-hederin—contribute synergistically to antimicrobial activity by disrupting bacterial cell membrane integrity (PMID 23646296).
Clinical Narrative (Provisional)
Current research consists primarily of in vitro and preclinical studies with limited human clinical trial data available. One immunomodulation study showed Nigella sativa oil increased CD4/CD8 T-cell ratios by 55% and enhanced NK cell function in human subjects. Essential oil demonstrates potent antimicrobial activity with minimum inhibitory concentrations of 2.69 μg/mL against Fusarium oxysporum and 0.67 μg/mL against Candida albicans. Well-controlled randomized clinical trials with quantified patient outcomes for diabetes, cancer, and other conditions remain insufficient to establish definitive therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.